Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
177Lu-NYM032 in Progressive PSMA-Positive mCRPC
NCT07795268Phase 3Not yet recruiting
- Sponsor
- Norroy Bioscience
- Start
- Aug 2026
- Primary completion
- Nov 2028
01
Overview
A Phase 3 trial of NY108 in prostate cancer (PCa), sponsored by Norroy Bioscience. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
NY108
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07795268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07795268.